<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医脉通血液科 | wechat-feeds</title><link>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</link><description>医脉通血液科主要提供国内外血液前沿资讯，热门血液指南，国内外血液会议报道，精彩血液病例！ “饕餮”血液，尽在医脉通血液科！</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 10 May 2021 19:21:01 +0800</pubDate><image><url>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</url><title>医脉通血液科 | wechat-feeds</title><link>http://MjM5OTA3MzIwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>口服阿扎胞苷和罗米地辛联合方案在PTCL中展现出较好疗效</title><link>https://mp.weixin.qq.com/s/eouFjSOX4k8lJd7X3nYgeQ</link><description></description><content:encoded><![CDATA[口服阿扎胞苷和罗米地辛联合方案在PTCL中展现出较好疗效]]></content:encoded><pubDate>Mon, 10 May 2021 17:25:14 +0800</pubDate></item><item><title>艾美赛珠单抗预防治疗A型血友病：HAVEN1-4研究长期随访结果</title><link>https://mp.weixin.qq.com/s/wOx7dx7IyqPsSH6oHmxK6Q</link><description></description><content:encoded><![CDATA[艾美赛珠单抗预防治疗A型血友病：HAVEN1-4研究长期随访结果]]></content:encoded><pubDate>Mon, 10 May 2021 17:25:14 +0800</pubDate></item><item><title>惊喜福利 | 麦粒、csco指南书籍、指南下载券任意选</title><link>https://mp.weixin.qq.com/s/yJtXuo9bcbM1F1aPVobf2A</link><description></description><content:encoded><![CDATA[惊喜福利 | 麦粒、csco指南书籍、指南下载券任意选]]></content:encoded><pubDate>Mon, 10 May 2021 17:25:14 +0800</pubDate></item><item><title>靶向BCMA的新CAR-T疗法，治疗多发性骨髓瘤值得期待</title><link>https://mp.weixin.qq.com/s/_FMXuOUi9WLnTLCVQkc1gg</link><description></description><content:encoded><![CDATA[靶向BCMA的新CAR-T疗法，治疗多发性骨髓瘤值得期待]]></content:encoded><pubDate>Mon, 10 May 2021 17:25:14 +0800</pubDate></item><item><title>强强联合丨四药方案D-KRd在NDMM患者中疗效显著</title><link>https://mp.weixin.qq.com/s/MwJwhae0kBhWJUFFvVynqQ</link><description></description><content:encoded><![CDATA[强强联合丨四药方案D-KRd在NDMM患者中疗效显著]]></content:encoded><pubDate>Sat, 08 May 2021 15:15:15 +0800</pubDate></item><item><title>漩涡里挣扎的中国医疗：让患者花钱的从来都不是医生</title><link>https://mp.weixin.qq.com/s/JKBRLOAsBcfhA2GL7oPojw</link><description></description><content:encoded><![CDATA[漩涡里挣扎的中国医疗：让患者花钱的从来都不是医生]]></content:encoded><pubDate>Sat, 08 May 2021 15:15:15 +0800</pubDate></item><item><title>罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生</title><link>https://mp.weixin.qq.com/s/gKKi9g2vYVllCT2DPxQKew</link><description></description><content:encoded><![CDATA[罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生]]></content:encoded><pubDate>Sat, 08 May 2021 16:35:03 +0800</pubDate></item><item><title>维布妥昔单抗联合DHAP治疗R/R cHL展现可观疗效</title><link>https://mp.weixin.qq.com/s/hvbF7QIWHZxYRMTRTv8rfw</link><description></description><content:encoded><![CDATA[维布妥昔单抗联合DHAP治疗R/R cHL展现可观疗效]]></content:encoded><pubDate>Sat, 08 May 2021 16:35:03 +0800</pubDate></item><item><title>VIII因子活性降低，遗传还是获得性？</title><link>https://mp.weixin.qq.com/s/8wb1hW6lIY5ZW8X-m2by5w</link><description></description><content:encoded><![CDATA[VIII因子活性降低，遗传还是获得性？]]></content:encoded><pubDate>Sat, 08 May 2021 16:35:03 +0800</pubDate></item><item><title>参会指南 | 中华医学会第一次全国浆细胞疾病学术会议​</title><link>https://mp.weixin.qq.com/s/HUi3OGxw00Wk-KPPONYV8g</link><description></description><content:encoded><![CDATA[参会指南 | 中华医学会第一次全国浆细胞疾病学术会议​]]></content:encoded><pubDate>Sat, 08 May 2021 16:35:03 +0800</pubDate></item><item><title>王建祥教授：国内新获批的DRd/DVd联合疗法助力实现首次复发MM“深度缓解、更长生存”的治疗目标</title><link>https://mp.weixin.qq.com/s/0V1nyuMGGDpbhJt6WfYarw</link><description></description><content:encoded><![CDATA[王建祥教授：国内新获批的DRd/DVd联合疗法助力实现首次复发MM“深度缓解、更长生存”的治疗目标]]></content:encoded><pubDate>Fri, 07 May 2021 17:28:22 +0800</pubDate></item><item><title>维布妥昔单抗在儿童初诊cHL中大有可为</title><link>https://mp.weixin.qq.com/s/Vp7fJUi9iRfRe-nFEQ7eRQ</link><description></description><content:encoded><![CDATA[维布妥昔单抗在儿童初诊cHL中大有可为]]></content:encoded><pubDate>Fri, 07 May 2021 17:28:22 +0800</pubDate></item><item><title>ROCK2抑制剂Belumosudil有望为难治cGVHD患者带来新希望</title><link>https://mp.weixin.qq.com/s/UUSVwcDe9RkT_i4RLqSKbw</link><description></description><content:encoded><![CDATA[ROCK2抑制剂Belumosudil有望为难治cGVHD患者带来新希望]]></content:encoded><pubDate>Fri, 07 May 2021 17:28:22 +0800</pubDate></item><item><title>缓解率100%！创新通用型CAR-T细胞疗法，有望拯救致命白血病</title><link>https://mp.weixin.qq.com/s/EWDCqp7j3EPTuTsb9YfqjA</link><description></description><content:encoded><![CDATA[缓解率100%！创新通用型CAR-T细胞疗法，有望拯救致命白血病]]></content:encoded><pubDate>Fri, 07 May 2021 17:28:22 +0800</pubDate></item><item><title>【淋巴瘤微课】中国慢性淋巴细胞白血病特征性遗传学异常</title><link>https://mp.weixin.qq.com/s/G4AAfO_WntFS3k5jrxqFkQ</link><description></description><content:encoded><![CDATA[【淋巴瘤微课】中国慢性淋巴细胞白血病特征性遗传学异常]]></content:encoded><pubDate>Thu, 06 May 2021 17:28:02 +0800</pubDate></item><item><title>如何降低儿童HCT后肺损伤的发生率？</title><link>https://mp.weixin.qq.com/s/ftdieodBrx5SdUAHX15GZA</link><description></description><content:encoded><![CDATA[如何降低儿童HCT后肺损伤的发生率？]]></content:encoded><pubDate>Thu, 06 May 2021 17:28:02 +0800</pubDate></item><item><title>临研人必读 | 软件演示：教会大家操作iBOIN设计</title><link>https://mp.weixin.qq.com/s/nWWjKbt1rDWycoA3BWdHjA</link><description></description><content:encoded><![CDATA[临研人必读 | 软件演示：教会大家操作iBOIN设计]]></content:encoded><pubDate>Thu, 06 May 2021 17:28:02 +0800</pubDate></item><item><title>BOC/BOA 2021 China会议日程框架</title><link>https://mp.weixin.qq.com/s/PUVXKU9v_4yHonPnT8tAww</link><description></description><content:encoded><![CDATA[BOC/BOA 2021 China会议日程框架]]></content:encoded><pubDate>Thu, 06 May 2021 17:28:02 +0800</pubDate></item><item><title>如何判断成人高危Ph-ALL是否需要异基因造血干细胞移植？</title><link>https://mp.weixin.qq.com/s/xEu12ywn_Xd3uUQfr0hZFA</link><description></description><content:encoded><![CDATA[如何判断成人高危Ph-ALL是否需要异基因造血干细胞移植？]]></content:encoded><pubDate>Tue, 04 May 2021 13:03:26 +0800</pubDate></item><item><title>医院14个科室招聘，男性优先！女性就业处于濒危境地……</title><link>https://mp.weixin.qq.com/s/arG3qOaD51dK5EvuuOoQkA</link><description></description><content:encoded><![CDATA[医院14个科室招聘，男性优先！女性就业处于濒危境地……]]></content:encoded><pubDate>Tue, 04 May 2021 13:03:26 +0800</pubDate></item></channel></rss>